Q4 2021 Talis Biomedical Corp Earnings Call Transcript
Good day, and thank you for standing by, and welcome to the Talis Biomedical's Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to Emily Faucette, Senior Vice President, Corporate Communications and Investor Relations. Please go ahead.
Good afternoon, and thank you for participating in Talis' Fourth Year -- Fourth Quarter and Year-end Conference Call. Joining me today are Rob Kelly, our Chief Executive Officer; and Roger Moody, our Chief Financial Officer.
Earlier today, the company released financial results and the business update for the quarter and full year ended December 31, 2021. A copy of that press release can be accessed on the Investors page of our website at talisbio.com.
Before we get started, I would like to remind you that management will make remarks during this call that are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |